Skip to content
★ Sign in to follow
RD

Robert D. Mitchell

CEO
Endologix Inc /DE/Angiodynamics Inc
Total declarations
55
Companies
2
▲ Purchases (1 ops.)
€8,552
▼ Sales (14 ops.)
€1.3M

Latest filing published 20 Jun 2017 for ENDOLOGIX INC /DE/.

Filing timeline

BuySale
Robert D. Mitchell

Insider track record

Disclosed buys
1
Disclosed sells
14
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Robert D. Mitchell: trading record in brief

Robert D. Mitchell has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Endologix Inc /DE/ and Angiodynamics Inc. The record holds 55 filings, for trades running from 2 April 2007 to 19 June 2017.

Both buying and selling appear: 1 purchase worth €8,552, against 14 sales worth €1.3M. The net balance comes to €1.3M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 38 share grants. 2017 to date brings 1 purchase and no sales.

The record was last updated on 20 June 2017 with a transaction in Endologix Inc /DE/. The latest purchase dates back some time: it was published 3,457 days ago, on 22 May 2017. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Robert D. Mitchell

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations53 total

25 of 53 declarations